📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 759 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
759
இன்று
169,460
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
50,092
நேர்மறை
8,647
எதிர்மறை
100,885
நடுநிலை
9,768
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
1,000+ அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: LT
நேர்மறை தாக்கம் 6/10 BOARD_MEETING

Unihealth Hospitals Approves Main Board Migration and Rs 26 Cr Loan Conversion in Subsidiary

Unihealth Hospitals Limited has approved migrating its equity shares from the NSE SME Emerge platform to the Main Boards of both NSE and BSE, subject to shareholder and regulatory approvals. The Board also approved the conversion of Rs 26.00 crore in loans into equity shares by its subsidiary, UMC Hospitals Private Limited. Additionally, the company is seeking shareholder approval to vary the terms of IPO proceeds utilization outlined in its September 14, 2023 prospectus. A Postal Ballot notice has been authorized to seek shareholder consent for these proposals.

நடுநிலை தாக்கம் 5/10 M&A

Seamec Completes Sale of Bulk Carrier 'SEAMEC GALLANT' via UAE Subsidiary

Seamec Limited announced the completed sale of its bulk carrier vessel 'SEAMEC GALLANT' on September 17, 2026. The vessel was owned by the company's wholly owned subsidiary, Seamec International FZE. The transaction was finalized at 16:46 hours Singapore Time following the signing of the Protocol of Delivery and Acceptance. Financial proceeds from the sale were not disclosed in this filing.

கண்காணிப்பு தாக்கம் 6/10 M&A

Vipul Approves Merger of 6 Subsidiaries, Notes Exchange Penalties & Board Appointments

Vipul Limited's Board of Directors has accorded in-principle approval for the merger of six wholly-owned subsidiary companies into Vipul Limited under Section 233 of the Companies Act, 2013. The Board also noted non-compliances and penalties levied by stock exchanges during the current financial year and confirmed payments made in respect thereof. Additionally, the Board noted the appointment of two Independent Directors (Dipesh Jaswantlal Shah and Sunil Kumar Gupta) and approved the re-appointment of Ajay Arjit Singh for a second 5-year term.

நேர்மறை தாக்கம் 6/10 BOARD_MEETING

Emami Approves ₹282 Cr Share Buyback at up to ₹475/Share via Open Market

Emami Limited's Board has approved an open-market share buyback for an aggregate amount not exceeding ₹282.00 crore (₹28,200 lakh) at a maximum price of ₹475.00 per share. The maximum buyback price represents a 23.1% premium over the current market price of ₹385.9. The indicative maximum number of shares to be repurchased is 59,36,842, representing approximately 1.36% of the company's total paid-up equity share capital. The total buyback size constitutes 9.98% of the company's net worth and 1.67% of its market capitalization.

நேர்மறை தாக்கம் 5/10 விரிவாக்கம்

RailTel Secures ₹63.15 Cr LoI from Prasar Bharati for WAVES OTT Platform

RailTel Corporation of India has received a Letter of Intent (LoI) from Prasar Bharati (Broadcasting Corporation of India, Director General, Doordarshan). The estimated size of the order is ₹63.15 crore (including tax) for providing additional features and services on the existing WAVES OTT platform. The contract is scheduled to be executed by February 11, 2029, providing revenue visibility over roughly 2.5 years. Relative to RailTel's TTM revenue of ₹3,326 crore, this domestic service contract constitutes approximately 1.9%.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நேர்மறை தாக்கம் 6/10 ஒழுங்குமுறை

Alembic Pharma Receives USFDA EIR for Vadodara Bioequivalence Facility

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from the USFDA, marking the formal closure of the inspection at its Bioequivalence Facility in Vadodara, Gujarat. The inspection took place between March 3, 2025, and March 7, 2025. This clears regulatory compliance uncertainty for the facility, supporting Alembic's ongoing clinical and bioequivalence studies required for its US generic pipeline. With Alembic generating TTM revenue of ₹7,550 Cr, smooth USFDA compliance across all sites is critical for its targeted 15-20 annual US product launches.

நேர்மறை தாக்கம் 5/10 விரிவாக்கம்

Royal Orchid Hotels Launches 66-Key Regenta Magnus in Pune, Scaling to 105 Keys

Royal Orchid Hotels Ltd. (ROHL) has launched a new upscale property, Regenta Magnus, located in Viman Nagar, Pune, through its subsidiary Regenta Hotels Private Limited. The property currently opens with 66 operational rooms and suites (62 Club Rooms and 4 Executive Suites). An additional 39 rooms are scheduled to be operational by December 2026, bringing the total to 105 keys. The opening adds to ROHL's network of over 123 hotels in India as it pursues its Vision 2030 target of 22,000+ keys.

நேர்மறை தாக்கம் 7/10 மற்றவை

BMW Ventures Bags Rs 72.94 Cr Orders from Tata Projects with 100% Advance Payment

BMW Ventures Limited has secured two purchase orders totaling Rs 72.94 crore (inclusive of taxes) from Tata Projects Limited. The contract entails the supply of TMT Steel FE-550D Grade for the 3X800MW USCTPP-ADANI Project. The orders carry very favorable commercial terms, featuring a 100% advance payment with GST. Execution is scheduled swiftly within 8 weeks from the purchase order date.

நேர்மறை தாக்கம் 9/10 நிதி திரட்டல்

Viceroy Hotels allots ₹105.83 Cr shares via Rights Issue at ₹115 per share

Viceroy Hotels Limited has approved the allotment of 92,03,008 equity shares at an issue price of ₹115 per share (including a premium of ₹105) on a rights basis. The total fundraise amounts to ₹105.83 Cr, representing ~13% of the company's market cap of ₹814 Cr. Following the allotment, the paid-up share capital expands from 6.76 Cr shares (₹67.58 Cr) to 7.68 Cr shares (₹76.78 Cr). The rights issue was offered to existing shareholders excluding promoter and promoter group.

கண்காணிப்பு தாக்கம் 7/10 சட்டம்

CIRP Update: CoC Approves Eligibility Criteria, Invitation for EOI, and Form G Timelines

India Power Corporation Limited (formerly DPSC Limited), currently under Corporate Insolvency Resolution Process (CIRP) via NCLT Hyderabad Bench order dated May 15, 2026, reported voting outcomes of its 6th Committee of Creditors (CoC) meeting held on September 01, 2026. The CoC has approved the eligibility criteria for Prospective Resolution Applicants, along with the Invitation for Expression of Interest (EOI) and Form G timelines through e-voting. This marks a critical procedural milestone under IBC to invite potential resolution applicants to revive or acquire the company, which holds a Rs 712 Cr market cap and TTM revenue of Rs 683 Cr.

கண்காணிப்பு தாக்கம் 9/10 M&A

Indiabulls to acquire 70% stake in Fintech Cloud for ₹1,050 Cr via share swap

Indiabulls Limited has approved the acquisition of a 70% equity stake in Fintech Cloud Private Limited for a consideration of ₹1,050 crore, valuing the target company at ₹1,500 crore. The deal will be executed via an NCLT Scheme through the issuance of up to 21 crore fully paid-up equity shares of Indiabulls Limited. Fintech Cloud operates as a Loan Service Provider for NBFCs and reported gross revenue of ₹133.77 crore and PBT of ₹30.31 crore in FY 2025-26. Indiabulls will immediately appoint a majority of directors to the target's board, while final closing is expected in 9 to 12 months.

நேர்மறை தாக்கம் 6/10 நிதி திரட்டல்

NECC Shareholders Approve Fundraise via Loans & Convertible Warrants at 41st AGM

North Eastern Carrying Corporation Limited (NECCLTD) announced the results of its 41st AGM held on September 10, 2026, where all 8 resolutions were passed with over 99.9% approval. Key approvals include the issuance of convertible warrants on a preferential basis and raising funds via convertible secured/unsecured loans. Additionally, shareholders approved an increase in authorised share capital and the re-appointment of CMD Sunil Kumar Jain (remuneration up to Rs 85 Lakhs/year) and Whole-time Director Utkarsh Jain (remuneration up to Rs 60 Lakhs/year).

கண்காணிப்பு தாக்கம் 6/10 சட்டம்

India Power Corp (DPSC) Concludes 7th CoC Meeting; Votes on Consortium EOI Criteria

India Power Corporation Limited (formerly DPSC Limited), currently under Corporate Insolvency Resolution Process (CIRP) initiated on May 15, 2026, held its 7th Committee of Creditors (CoC) meeting on September 11, 2026. The CoC approved the engagement of Shardul Amarchand Mangaldas & Co. as legal counsel for CIRP litigation and advisory services. Additionally, the CoC deliberated on clarifications/addendums to eligibility criteria for consortium applicants under the Invitation for Expression of Interest (EOI), putting the matter to an upcoming e-voting process.

நடுநிலை தாக்கம் 5/10 நிர்வாகம்

UltraTech Appoints Ashish Chandra as CMO Designate; E R Raj Narayanan to Relinquish on March 31, 2027

UltraTech Cement has announced a planned leadership transition for its Chief Manufacturing Officer (CMO) role. Mr. Ashish Chandra is appointed as Chief Manufacturing Officer (Designate) and Senior Management Personnel effective September 16, 2026. Incumbent CMO Mr. E R Raj Narayanan will relinquish his role on March 31, 2027, following a transition period, after which Mr. Chandra will formally assume the CMO position on April 1, 2027. With Mr. Chandra possessing around 33 years of experience in manufacturing, this planned handover ensures operational continuity across UltraTech's massive grey cement capacity (targeting 200+ MTPA).

நேர்மறை தாக்கம் 6/10 ஒழுங்குமுறை

Alembic Pharma Clears Unannounced USFDA Inspection at Vadodara with Zero Form 483 Observations

Alembic Pharmaceuticals has successfully completed an unannounced onsite USFDA Bioequivalence inspection at its Vadodara facility with zero Form 483 observations. The inspection took place between August 31, 2026, and September 10, 2026. A clean regulatory outcome at bioequivalence sites is vital for the company's US pipeline and planned 15-20 product launches in FY26. For a company generating Rs 7,550 Cr in TTM revenue, avoiding compliance disruptions protects ongoing US export growth.

நேர்மறை தாக்கம் 5/10 சட்டம்

Telangana HC Quashes Rs 3.56 Cr Electricity Surcharge Demand on Viceroy Hotels Under IBC Sec 32A

Viceroy Hotels Limited has received a favorable order from the Hon'ble High Court of Telangana setting aside a demand notice of Rs 3.56 crore (Rs 3,55,99,834). The demand was issued on January 31, 2025, by Southern Power Distribution Company of TS Limited for cross-subsidy surcharges pertaining to FY 2005-06 to FY 2014-15. The High Court held that the company is entitled to Section 32A immunity under the Insolvency and Bankruptcy Code (IBC) following the successful completion of its CIRP in October 2023. The quashed demand represents approximately 15.5% of the company's TTM PAT of Rs 23 crore, removing a contingent cash outflow risk.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

NECC 41st AGM: Approves ₹18.51 Cr Promoter Warrants and Debt-to-Equity Option up to ₹50 Cr

North Eastern Carrying Corporation Limited held its 41st AGM on September 10, 2026, placing key capital structure resolutions before shareholders. The proposals include raising the authorised share capital from ₹110 Cr to ₹150 Cr, enabling headroom for equity expansion. Additionally, the company proposed issuing 1.0 Cr convertible warrants at ₹18.51 each to promoter Sunil Kumar Jain (aggregating ₹18.51 Cr, ~10.2% of market cap) and enabling lenders to convert up to ₹50 Cr of debt into equity or convertible instruments (representing ~40.3% of total debt). Voting results will be submitted separately.

நேர்மறை தாக்கம் 8/10 விரிவாக்கம்

Kolte-Patil achieves record >Rs 600 cr sales in 60 hours at Pune project launch

Kolte-Patil Developers announced its strongest-ever launch performance with sales exceeding Rs 600 crore in 60 hours for its project 'Vyana at The Reserve' in Vadgaon, Pune. The launch saw over 600 apartments booked across premium 2- and 3-bedroom configurations. This single launch booking value represents ~84% of the company's TTM revenue of Rs 714 crore, providing strong revenue visibility against recent quarterly losses. The overall project spans 20 acres with ~5 million sq. ft. of potential saleable area and a total expected Gross Development Value (GDV) of Rs 4,000 crore.

கண்காணிப்பு தாக்கம் 7/10 நிர்வாகம்

Sarthak Metals Reports Demise of Chief Financial Officer Narendra Dewangan

Sarthak Metals Limited has announced the sad demise of its Chief Financial Officer, Mr. Narendra Dewangan, on September 09, 2026. Mr. Dewangan had spent approximately two decades with the company and the Desraj Bansal Group, previously serving as Head of Accounts before his recent elevation to CFO. The company generated Rs 55.21 cr in revenue and Rs 1.33 cr in net profit in Q1 FY27 (quarter ended June 2026). The sudden loss creates a vacancy in the top financial leadership position.

நடுநிலை தாக்கம் 7/10 மற்றவை

TVS Holdings Allots 93.07 Cr Bonus 6% NCRPS Worth Rs 930.7 Cr Under Scheme

TVS Holdings Limited has approved the allotment of 93,06,76,784 Bonus 6% Cumulative Non-Convertible Redeemable Preference Shares (NCRPS) of face value Rs 10 each fully paid up. The bonus shares are issued in the ratio of 46 NCRPS for every 1 equity share of Rs 5 held as of the record date, 8th September 2026. The total face value of the NCRPS issued aggregates to approximately Rs 930.68 Cr, representing ~53% of the company's net worth of Rs 1,754 Cr. The preference shares carry a 6% annual coupon and will mature on 9th December 2027 (15 months from allotment), with board discretion to redeem after 12 months.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்